Assist. Prof. Dr. Magdalena Budzyń, Poznan University of Medical Sciences, Poland.
Dr. Magdalena Budzyń is an accomplished researcher and educator specializing in cardiovascular diseases and laboratory diagnostics. With a strong academic foundation from Poznan University of Medical Sciences, she earned her Ph.D. in Medical Sciences and later achieved the prestigious habilitated doctor qualification. Her research focuses on endothelial damage markers and their role in cardiovascular conditions, contributing valuable insights into disease mechanisms. As an Assistant Professor, she has been dedicated to both scientific discovery and mentoring future medical professionals.
Profile
Orcid
Early Academic Pursuits 🎓
Born on April 4, 1982, Dr. Magdalena Budzyń embarked on her academic journey with a passion for medical sciences. Her educational path began at Poznan University of Medical Sciences, where she pursued an in-depth study of laboratory diagnostics. She completed her Ph.D. in Medical Sciences between 2009 and 2013, focusing on the intricate balance between leukocyte elastase and its inhibitor alpha1-antitrypsin in chronic venous insufficiency. With an insatiable curiosity for cardiovascular research, she further advanced her academic credentials by earning a habilitated doctor degree in 2022, exploring circulating markers of endothelial damage and their clinical implications in cardiovascular diseases.
Professional Endeavors 🏅
Dr. Budzyń’s professional career has been a testament to her dedication to medical research and education. She has been an integral part of Poznan University of Medical Sciences since 2007, serving as an Assistant Professor. Prior to that, she gained valuable experience at Poznan Veterinary Institute as a Technical Assistant, where she honed her laboratory and analytical skills. Her expertise in laboratory medicine and medical chemistry has made her a respected academic in her field, contributing significantly to both research and teaching.
Contributions and Research Focus 🔬
Her research primarily revolves around cardiovascular diseases, with a particular emphasis on endothelial damage markers. By investigating the role of these biomarkers, she has provided critical insights into the pathophysiology of vascular disorders. Her work has contributed to the understanding of chronic venous insufficiency and how leukocyte elastase imbalance impacts disease progression. Additionally, her studies in laboratory diagnostics have strengthened the role of clinical biomarkers in predicting and managing cardiovascular conditions.
Accolades and Recognition 🏆
Dr. Budzyń’s academic excellence has been recognized through her habilitated doctor qualification, a prestigious milestone in her career. Her contributions to medical sciences have been acknowledged within the scientific community, as she continues to shape the field of cardiovascular research. Her role as an educator and mentor further amplifies her influence, guiding students toward meaningful research endeavors in laboratory medicine and diagnostics.
Impact and Influence 🌍
Beyond academia, Dr. Budzyń’s research has a profound impact on the medical field, particularly in improving diagnostic tools for cardiovascular diseases. Her findings contribute to enhanced patient care by identifying key biomarkers that aid in early disease detection and treatment planning. She actively collaborates with researchers and medical professionals, ensuring that her work bridges the gap between scientific discovery and clinical application.
publication
-
Significance of the monocyte CCR2-CCL2 axis in triple-negative breast cancer
Authors: Magdalena Budzyń, Agata Kubicka, Elżbieta Kaja, Witold Kycler, Joanna Załuska-Kusz, Jacek J. Brzeziński, Marcelina Sperling, Alicja Bukowska, Joanna Grupińska
Year: 2025
-
Nutritional Behaviors, Vitamin Supplementation and Physical Activity among Polish Adults during the COVID-19 Pandemic
Authors: Bogna Gryszczyńska, Magdalena Budzyń, Joanna Grupińska, Magdalena Paulina Kasprzak, Agnieszka Gryszczyńska
Year: 2022
-
Beneficial Effects of Oral Nutritional Supplements on Body Composition and Biochemical Parameters in Women with Breast Cancer Undergoing Postoperative Chemotherapy: A Propensity Score Matching Analysis
Authors: Joanna Grupińska, Magdalena Budzyń, Kalina Maćkowiak, Jacek Jakub Brzeziński, Witold Kycler, Ewa Leporowska, Bogna Gryszczyńska, Magdalena Paulina Kasprzak, Maria Iskra, Dorota Formanowicz
Year: 2021
-
Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor sRAGE, and Uric Acid
Authors: Bogna Gryszczyńska, Magdalena Budzyń, Dorota Formanowicz, Maria Wanic-Kossowska, Piotr Formanowicz, Wacław Majewski, Maria Iskra, Magdalena P. Kasprzak
Year: 2020
-
Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension
Authors: Magdalena Budzyń
Year: 2019
-
Advanced Oxidation Protein Products and Carbonylated Proteins Levels in Endovascular and Open Repair of an Abdominal Aortic Aneurysm: The Effect of Pre-, Intra-, and Postoperative Treatment
Authors: Bogna Gryszczyńska, Magdalena Budzyń, Dorota Formanowicz, Piotr Formanowicz, Zbigniew Krasiński, Natalia Majewska, Maria Iskra, Magdalena P. Kasprzak
Year: 2019
Conclusion
Dr. Budzyń’s contributions to medical sciences extend beyond academia, influencing the fields of laboratory diagnostics and cardiovascular research. Her work has significantly improved the understanding of endothelial dysfunction and biomarker-based diagnostics, paving the way for better clinical applications. With her ongoing dedication to research and education, she continues to inspire the next generation of scientists while striving to make impactful advancements in medical science.